Moreover, the 36-month beta value for NVRO is 0.88. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 5 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NVRO is 35.17M and currently, short sellers hold a 8.91% of that float. On November 12, 2024, NVRO’s average trading volume was 519.96K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NVRO) stock’s latest price update
Nevro Corp (NYSE: NVRO)’s stock price has gone rise by 2.57 in comparison to its previous close of 5.32, however, the company has experienced a -1.85% decrease in its stock price over the last five trading days. prnewswire.com reported 2024-11-12 that HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark evidence with cloud data insights, leading the way for personalized, data-driven patient care* REDWOOD CITY, Calif., Nov. 12, 2024 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has received CE Mark Certification in Europe for its HFX iQ™ spinal cord stimulation (SCS) system.
NVRO’s Market Performance
Nevro Corp (NVRO) has experienced a -1.85% fall in stock performance for the past week, with a 10.91% rise in the past month, and a 5.75% rise in the past quarter. The volatility ratio for the week is 8.96%, and the volatility levels for the past 30 days are at 7.13% for NVRO. The simple moving average for the past 20 days is 4.31% for NVRO’s stock, with a -43.34% simple moving average for the past 200 days.
Analysts’ Opinion of NVRO
Wells Fargo gave a rating of “Underweight” to NVRO, setting the target price at $5.50 in the report published on August 07th of the current year.
NVRO Trading at 4.24% from the 50-Day Moving Average
After a stumble in the market that brought NVRO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.90% of loss for the given period.
Volatility was left at 7.13%, however, over the last 30 days, the volatility rate increased by 8.96%, as shares surge +13.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.05% upper at present.
During the last 5 trading sessions, NVRO rose by +4.86%, which changed the moving average for the period of 200-days by -66.93% in comparison to the 20-day moving average, which settled at $5.25. In addition, Nevro Corp saw -74.64% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NVRO
Current profitability levels for the company are sitting at:
- -0.22 for the present operating margin
- 0.66 for the gross margin
The net margin for Nevro Corp stands at -0.18. The total capital return value is set at -0.19. Equity return is now at value -24.78, with -11.98 for asset returns.
Based on Nevro Corp (NVRO), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at -0.28. The debt to equity ratio resting at 0.8. The interest coverage ratio of the stock is -5.2.
Currently, EBITDA for the company is -87.77 million with net debt to EBITDA at -2.19. When we switch over and look at the enterprise to sales, we see a ratio of 0.88. The receivables turnover for the company is 5.74for trailing twelve months and the total asset turnover is 0.71. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.02.
Conclusion
To wrap up, the performance of Nevro Corp (NVRO) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
